HOW TOLERABLE IS METHOTREXATE IN THE LONG-TERM USE IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)?

被引：1
|
作者：
Minden, K. [1 ,2 ]
Klotsche, J. [3 ]
Niewerth, M. [3 ]
Zink, A. [1 ]
Seipelt, E. [4 ]
Haas, J. -P. [5 ]
Ganser, G. [6 ]
Horneff, G. [7 ]
机构：
[1] German Rheumatism Res Ctr, Epidemiol Unit, Berlin, Germany
[2] Univ Med Charite, Berlin, Germany
[3] German Rheumatism Res Ctr, Berlin, Germany
[4] Immanuel Krankenhaus, Berlin, Germany
[5] Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany
[6] St Josef Stift, Sendenhorst, Germany
[7] Asklepios Kinderklin, St Augustin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.5173
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0498
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [31] Recommendations for the use of methotrexate in juvenile idiopathic arthritis
    Niehues T.
    Lankisch P.
    Pediatric Drugs, 2006, 8 (6) : 347 - 356
  • [32] Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
    Mori, Masaaki
    Naruto, Takuya
    Imagawa, Tomoyuki
    Murata, Takuji
    Takei, Syuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2009, 19 (01) : 1 - 11
  • [33] LITERATURE REVIEW ON THE THE USE OF CORTICOSTEROIDS IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Deepak, S.
    Baildam, E.
    McErlane, F.
    RHEUMATOLOGY, 2017, 56
  • [34] Enthesitis in Juvenile Idiopathic Arthritis (JIA)
    Rumsey, Dax G.
    Guzman, Jaime
    Rosenberg, Alan
    Huber, Adam
    Scuccimarri, Rosie
    Eurich, Dean
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [35] The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis
    Bartoli, M.
    Taro, M.
    Magni-Manzoni, S.
    Pistorio, A.
    Traverso, F.
    Viola, S.
    Magnani, A.
    Gasparini, C.
    Martini, A.
    Ravelli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 370 - 374
  • [36] Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
    Yueh Su
    Yao-Hsu Yang
    Bor-Luen Chiang
    Clinical Rheumatology, 2017, 36 : 1997 - 2004
  • [37] HOW COMMON IS METHOTREXATE INTOLERANCE IN JUVENILE IDIOPATHIC ARTHRITIS?
    Khan, Mohammad Saad
    Pijoan-Moratalla, Cristina
    Lee, Martin A.
    RHEUMATOLOGY, 2019, 58
  • [38] Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
    Su, Yueh
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 1997 - 2004
  • [39] What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
    Swart, Joost F.
    de Roock, Sytze
    Wulffraat, Nico M.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (03)
  • [40] What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
    Joost F Swart
    Sytze de Roock
    Nico M Wulffraat
    Arthritis Research & Therapy, 15
12345